Learn About Venous Thromboembolism (VTE)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Venous Thromboembolism (VTE) Local Doctors?
Learn about our expert tiers
Learn more
What are the Latest Advances for Venous Thromboembolism (VTE)?
ABCL-104 Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Hematological Malignancies.
Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce.
Tired of the same old research?
Check Latest Advances
What are the latest Venous Thromboembolism (VTE) Clinical Trials?
Predicting and Preventing Poor Outcomes of Venous Thromboembolism in Children

Summary: 'The TOP Study' is a prospective cohort study whose main objective is to develop better prognostic biomarkers and identify children at risk of adverse thrombotic outcomes very early in the course after an initial venous thromboembolic events (VTE). The study will compare biomarkers in children that develop poor VTE outcomes (such as recurrence, postthrombotic syndrome and post PE impairment ) afte...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective Validation of the 4TS Risk Assessment Model in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias. ROADMAP-MM

Summary: Patients with newly diagnosed symptomatic multiple myeloma per IMWG criteria prior to therapy initiation are enrolled in the study. The aim of the study is to investigate clinical and disease related risk factors for venous thromboembolism (VTE) in these patients as well as possible biomarkers of hypercoagulability linked with the occurrence of venous thromboembolism at diagnosis and during the di...